Akura Medical
United States
- Los Gatos, California
- 04/10/2023
- Series B
- $35,000,000
Focused on providing effective and easy-to-use clot removal to efficiently treat venous thromboembolisms (VTE)
- Industry Medical Device
- Website https://www.akuramed.com/
- LinkedIn https://www.linkedin.com/company/akura-med/about/
Related People
Murali SrivathsaFounder
United States -
San Francisco Bay Area
Mission-driven, versatile Medical Devices leader who can introduce bold solutions and strategic plans which drive rapid business and operational growth, translate cutting-edge concepts into game-changing commercial offerings, and seize emerging opportunities through a balanced mix of strategic partnerships, financial planning, and business due diligence. The answer to my "Why?" is to make a transformative change in the lives of patients and those who treat them.
✓ Consistently delivers high growth/profitability through vital blend of product innovation and commercialization, go-to-market strategies, transformational approaches to Education & Training, and operational plans. Proven business and leadership record honed across multiple functions from management to strategy, M&A, to R&D.
✓ Credited with leading matrix organizations in the development of next-gen product lines at Abbott and Guidant (Boston Scientific CRM), accounting for $900+Mn in annual revenues.
✓ Expert relationship management skills and emotional intelligence to build high-performance internal cross-functional teams, as well as long-lasting external strategic partnerships.
✓ Experience with building funding strategies and leading fundraises.
✓ Enjoys the challenges of new initiatives- excels at being able to add value with a singular combination of scientific and business acumen.
✓ Broad experience in both domestic and international markets.
WealthAi | $1,000,000 | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)
PaleBlueDot AI | $150,000,000 | (Jan 30, 2026)
Mesh Security | $12,000,000 | (Jan 30, 2026)
Datalinx AI | $4,200,000 | (Jan 30, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Co-reactive | $7,754,157 | (Jan 30, 2026)
Arkero | $6,000,000 | (Jan 30, 2026)
Redwood Materials | $425,000,000 | (Jan 30, 2026)
Twogee Biotech | $2,575,886 | (Jan 30, 2026)
Levellr | $2,500,000 | (Jan 30, 2026)
Indigo(1) | $50,000,000 | (Jan 30, 2026)
heyData | $16,500,000 | (Jan 30, 2026)